A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
11/1997
11/06/1997	WO1997041208A1 Skin regeneration using mesenchymal stem cells
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	CA2253724A1 Skin regeneration using mesenchymal stem cells
11/06/1997	CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof
11/06/1997	CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
11/05/1997	EP0805162A1 Peptide determinant associated with immunity
11/05/1997	EP0804734A1 Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
11/05/1997	EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
11/05/1997	EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804551A1 Bone precursor cells: compositions and methods
11/05/1997	EP0804550A1 Ex vivo activation of immune cells
11/05/1997	EP0804549A1 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity
11/05/1997	EP0804483A1 Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules
11/05/1997	EP0804283A1 Aqueous solvent encapsulation method, apparatus and microcapsules
11/05/1997	EP0804254A1 Heat treated blood plasma proteins
11/05/1997	EP0804219A1 Inhibin compositions and methods of use thereof
11/05/1997	EP0804218A1 Product and process for regulating signal transduction pathways
11/05/1997	EP0804211A1 Aqueous cell extracts and aqueous suspensions of cell wall fractions from mycobacteria
11/05/1997	EP0804210A1 Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells
11/05/1997	EP0804207A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
11/05/1997	EP0804076A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
11/05/1997	EP0804072A1 Method and system for cultivating cells particularly macrophages
11/05/1997	CN1164190A Cell growth regulator
11/05/1997	CN1163776A Medicine for treating hepatic disease
11/05/1997	CN1163775A Shenluzhuangyuan wine containing ginseng and other Chinese medicine and producing process thereof
11/05/1997	CN1163725A Health beverage and producing process thereof
11/05/1997	CN1163707A Appetizing spleen-tonifying nutritive food
11/04/1997	USRE35653 In vivo delivery of neurotransmitters by implanted, encapsulated cells
11/04/1997	US5683984 Enteral tube feeding composition with a native micellar casein protein component
11/04/1997	US5683865 Method for diagnosis of mystery swine disease
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	US5683690 Canine lymphoma and feline leukemia
10/1997
10/30/1997	WO1997040137A1 Regeneration and augmentation of bone using mesenchymal stem cells
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997039767A1 Methods for inducing bone formation
10/30/1997	WO1997039761A1 A process for viral inactivation of lyophilized blood proteins
10/30/1997	WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997	WO1997035021A3 Prostate specific antigen oligo-epitope peptide
10/30/1997	WO1997025426A3 Compositions and methods for the treatment and diagnosis of breast cancer
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2251808A1 Methods for inducing bone formation
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0116571B2 Method for making gamma globulin-containing compositions
10/29/1997	CN1163571A Compositions containing at least one glucocorticoid in combination with pulmonary surfactant for treatment of IRDS and ARDS
10/29/1997	CN1163309A Lumbricus wine and its producing method
10/29/1997	CN1163141A External application medicine for curing rheumatic and rheumatoid arthritis
10/29/1997	CN1163132A Oral liquor for giving up drug
10/29/1997	CN1163131A Fengdan oral liquid and its preparation process
10/29/1997	CN1163124A Decoction for curing cerebral vasscular diseases and its producing method
10/29/1997	CN1163122A Seabuckthorn fruit yolk health oil and its producing method
10/29/1997	CN1163117A Double-effect preparation for curing prospermia and killing venereal bacteria
10/29/1997	CN1163112A Micro ecologic regulator containing active bacteria and its preparing technology
10/29/1997	CN1163111A Processing technology for leech powder without fish smell
10/29/1997	CN1163110A Preservation and utilization of mixed bull and goat sperm
10/28/1997	US5681847 Administering anticarcinogenic lactone compounds
10/28/1997	US5681746 Genetic engineering
10/28/1997	US5681709 Adjusting the red blood cell automatic processor to contact all or a part of dispersion of erythrocytes with proteolytic enzyme soltion to modify atleast a portion or a portion or all the dispersion to form red blood cell reagent
10/28/1997	US5681587 Contacting with laminin
10/28/1997	US5681561 Compositions and methods for improving autologous fat grafting
10/28/1997	US5681559 Method for producing a highly enriched population of hematopoietic stem cells
10/28/1997	US5681556 Method and compositions for suppressing allograft rejection in mammals
10/23/1997	WO1997039118A1 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
10/23/1997	WO1997039111A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	WO1997039108A1 Process for producing and multiplying lymphocytes
10/23/1997	WO1997039107A2 Methods for increasing the maturation of cells
10/23/1997	WO1997039104A1 Cryopreservation and extensive subculturing of human mesenchymal stem cells
10/23/1997	WO1997039023A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects
10/23/1997	WO1997039022A1 Novel compounds
10/23/1997	WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997	WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997	WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997	WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997	WO1997038722A1 Novel compounds
10/23/1997	WO1997038719A1 Novel compounds
10/23/1997	WO1997038718A1 Novel compounds
10/23/1997	WO1997038717A1 Novel compounds
10/23/1997	WO1997038707A1 Method and device for delivery of apoptosis-inducing molecules
10/23/1997	WO1997026862A3 Improved concentrated injection and infusion solutions for intravenous administration
10/23/1997	DE19615293A1 Propolis skin disorder salve
10/23/1997	CA2251724A1 Compositions containing bacteriophages and methods of using bacteriophages to treat infections
10/23/1997	CA2250707A1 Cysteine-containing or methionine-containing peptides with immunomodulatory effects
10/22/1997	EP0802257A1 Human colon epithelial immortalized cell lines
10/22/1997	EP0801953A1 Medical device for the extracorporal blood or plasma treatment and methods for the manufacture of such device
10/22/1997	EP0801676A2 New artificial tissue, method for the production and the use thereof
10/22/1997	EP0801575A1 Retroviral vectors for expression in embryonic cells
10/22/1997	EP0679093B1 Methods of delivering agents to target cells
10/22/1997	EP0228458B2 Epithelial cells expressing foreign genetic material
10/22/1997	CN1162636A Spiral algae spirit and brewage thereof
10/22/1997	CN1162634A health-care beer and brewage thereof
10/22/1997	CN1162488A Medicine for complicated urinary infection
10/22/1997	CN1162485A Medicine for curing bilestone and biliary calculus
10/22/1997	CN1162484A Compounded Chuanlin Dingchuan capsule for asthma
10/22/1997	CN1162481A External use cream for skin pigmentation
10/22/1997	CN1162480A Powder for curing hepatitis
10/22/1997	CN1162467A External use medicine for curing scars

1 ... 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 ... 1259